CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 69 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q4 2020. The put-call ratio across all filers is 57.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $34,000 | +240.0% | 1,875 | +228.9% | 0.00% | – |
| Q3 2020 | $10,000 | -33.3% | 570 | -41.2% | 0.00% | – |
| Q2 2020 | $15,000 | -40.0% | 969 | -36.0% | 0.00% | – |
| Q4 2019 | $25,000 | +56.2% | 1,515 | +42.8% | 0.00% | – |
| Q3 2019 | $16,000 | -5.9% | 1,061 | +3.8% | 0.00% | – |
| Q2 2019 | $17,000 | +466.7% | 1,022 | +527.0% | 0.00% | – |
| Q4 2018 | $3,000 | +200.0% | 163 | +103.8% | 0.00% | – |
| Q3 2018 | $1,000 | -50.0% | 80 | -2.4% | 0.00% | – |
| Q2 2018 | $2,000 | – | 82 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|